Male germ-like cell differentiation potential of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells in co-culture with human placenta cells in presence of BMP4 and retinoic acid
(ندگان)پدیدآور
Ataie nejad, NahidAmidi, FardinAgha Hoseini, MarziyehNayer Nia, KarimHabibi, MehryarKajbafzadeh, Abdol MohammadMazaheri, ZohrehYamini, Nazilaنوع مدرک
TextOriginal Article
زبان مدرک
Englishچکیده
Objective(s):Mesenchymal stem cells (MSCs) derived from Wharton's jelly (WJ-MSCs) are now much more appealing for cell-based infertility therapy. Hence, WJ-MSCs differentiation toward germ layer cells for cell therapy purposes is currently under intensive study.
Materials and Methods: MSCs were isolated from human Wharton's jelly and treated with BMP4, retinoic acid (RA) or co-cultured on human amniotic epithelial (HAE) and chorionic plate (HCP) placenta feeder cells. profile of POU5F1, Fragilis, Plzf, DDX4, Piwil2, Stra8, Dazl, β1- and α6-integrins (ITΒ1, ITA6) genes expression as germ cell markers were analyzed using RT-PCR and real-time PCR. Immunocytochemistry of surface markers were conducted.
Results: After 3 weeks treatment with different reagents and co-culture system, morphology of WJ-MSCs changed to shiny clusters and germ cell specific markers in mRNA were up-regulated in both placental feeder + RA and BMP4 + RA. Induction of hWJ-MSCs with BMP4 in presence of RA resulted in significant up-regulation (P≤0.05) of all germ cell specific genes (c-Kit; 2.84±0.59, DDX4; 1.69±0.39, Piwil2; 1.14±0.21, Dazl; 0.65±0.25, α6 integrin; 1.26±0.53, β1 integrins; 1.18±0.65) compared to control and placental feeder cells + RA. Our results indicated that HAE and HCP followed by RA treatment were involved in human germ cell development.
Conclusion: We demonstrated that under the right conditions, hWJ-MSCs have the ability to differentiate to germ cells and this provides an excellent pattern to study infertility cause and treatment.
کلید واژگان
Mesenchymal stem cellPGC
Placenta
Spermatogonial stem cell
Wharton’s jelly
شماره نشریه
4تاریخ نشر
2015-04-011394-01-12
ناشر
Mashhad University of Medical Sciencesسازمان پدید آورنده
Department of Reproductive Biology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, IranDepartment of Anatomical Sciences, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
IVF Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
Institute for Molecular Medicine and Cell Therapy, Düsseldorf, Germany and GENEOCELL, Advanced Molecular & Cellular Technologies, Tehran, Iran
Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
Pediatric Urology Research Center, Children Hospital Medical Center, Tehran University of Medical Sciences, Tehran, Iran
Department of Anatomical Sciences, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
Department of Reproductive Biology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
شاپا
2008-38662008-3874




